• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Tazarotene vs. Tretinoin

Article

San Francisco - Tazarotene 0.1 percent cream (Avage) and tretinoin 0.05 percent emollient cream (Renova) are both effective adjunctive agents for mitigating signs of facial photodamage, but results of a six-month, double-blind, parallel comparative trial indicate tazarotene offers the potential for earlier and greater results, said Nicholas J. Lowe, M.D.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.